Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Keverprazan in Treating H. Pylori：A Randomized Controlled, Multicenter,Prospective Clinical Study

NCT06851468 is registered in ClinicalTrials.gov with Key Laboratory for Gastrointestinal Diseases of Gansu Province as lead sponsor.

NCT NCT06851468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06851468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Keverprazan in Treating H. Pylori：A Randomized Controlled, Multicenter,Prospective Clinical Study
Lead sponsor
Key Laboratory for Gastrointestinal Diseases of Gansu Province
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2025
Completion date
November 30, 2025
Enrollment
264 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori